Faculty

Collaborators

Stephen V Faraone, Ph.D.

Professor of Psychiatry and Behavioral Sciences; Director, Medical Genetics Research Center
Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University

Mentor and Collaborator on “Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan” (R01 MH 085521), “Functional Evaluation of DRD2 Variants Conferring Risk for Schizophrenia” (NARSAD Young Investigator Award), and “Reverse Genomic Approach to Defining Behavioral, Neurodevelopmental, and Psychiatric Disorders in Children” (SUNY Upstate Medical University Start-Up Award)

Gregory S. Liptak M.D., M.P.H.

Professor of Pediatrics; Director, Center for Behavior, Development and Genetics
Department Pediatrics & Center for Development, Behavior and Genetics, SUNY Upstate Medical University

Collaborator on “Reverse Genomic Approach to Defining Behavioral, Neurodevelopmental, and Psychiatric Disorders in Children” (SUNY Upstate Medical University Start-Up Award)

Wendy R. Kates, Ph.D.

Professor of Psychiatry and Behavioral Sciences
Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University

Collaborator on “Reverse Genomc Approach to Defining Behavioral, Neurodevelopmental, and Psychiatric Disorders in Children” (SUNY Upstate Medical University Start-Up Award) and and 22q11.2 Genes and Autism (Autism Speaks)

Extramural Collaborators

Ming T. Tsuang, M.D., Ph.D., D.Sc. External link

Distinguished University Professor, University of California;
Behavioral Genomics Chair and Director, Center for Behavioral Genomics,Department of Psychiatry, University of California, San Diego;
Director, Harvard Institute of Psychiatric Epidemiology and Genetics, Harvard Medical School and Harvard School of Public Health.

Mentor, Collaborating PI on “Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan” (R01 MH 085521 and R01 MH 085560, and Collaborator on numerous projects, including “Biomarkers for Marine PTSD Risk and Resilience” (R21 MH 085240), “Functional Evaluation of DRD2 Variants Conferring Risk for Schizophrenia” (NARSAD Young Investigator Award), “Genetic Predictors of Neuropsychological and Functional outcomes in Schizophrenia” (R01 MH 081861), and Imaging Autism Biomarkers & Risk Genes (P50 MH 081755-020003).